COMMUNIQUÉS West-GlobeNewswire

ABLYNX ANNOUNCES BOARD CHANGES
08/01/2018
8 January 2018 - 5:30 pm CET GHENT, Belgium, 8 January 2018 (5:30 pm CET) - Ablynx NV [Euronext Brussels and Nasdaq: ABLX] today announced that Dr Peter Fellner, who has served as Chairman since 2013 [1] , has decided [...]
Ossur Hf : Transactions in relation to share buyback program
08/01/2018
Announcement from Össur hf. No. 2/2018 Reykjavík, 8 January 2018 On 15 August 2017, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2017. The purpose of the share buyback program is to [...]
Stratos Genomics Raises Funds to Ready for Commercialization
08/01/2018
SEATTLE, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Stratos Genomics, Inc. , a 4th generation DNA sequencing technology company, today announced it has raised $20 million in venture capital from Fisk Ventures. The funds will be [...]
I-PEN®, I-DROP® and I-PLUG® now available in Spain and Portugal through Partnership with IMEX
08/01/2018
MONTREAL, Jan. 08, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma, Inc., a Canadian company specializing in dry eye diagnosis and management, announced today the signing of an exclusive agreement with IMEX for distribution of it [...]
I-PEN®, I-DROP® et I-PLUG® maintenant offerts en Espagne et au Portugal grâce à un partenariat avec IMEX
08/01/2018
MONTRÉAL, 08 janv. 2018 (GLOBE NEWSWIRE) -- I-MED Pharma inc., une entreprise canadienne spécialisée dans le diagnostic et la prise en charge de la sécheresse oculaire, a annoncé aujourd’hui la signature d’une entente [...]
HealthEquity Announces Strong Sales, Presentation at JP Morgan Healthcare Conference
08/01/2018
DRAPER, Utah, Jan. 08, 2018 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY ) (“HealthEquity” or the “Company”), the nation’s largest health savings account (“HSA") non-bank custodian, today announced significant [...]
Aptevo Therapeutics Begins Patient Dosing in Phase 2 Clinical Trial of Otlertuzumab in Peripheral T-Cell Lymphoma
08/01/2018
SEATTLE, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (Nasdaq: APVO ), a biotechnology company focused on developing novel oncology and hematology therapeutics, today announced that it has commenced [...]
Alphatec Announces Preliminary Fourth Quarter and Full Year 2017 Revenue and Corporate Updates
08/01/2018
CARLSBAD, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“Alphatec” or the “Company”) (Nasdaq: ATEC ), a provider of innovative spine surgery solutions with a mission to improve patient lives through [...]
Progyny Reports Over 100% Revenue Growth in 2017
08/01/2018
New York, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Progyny, the leading fertility benefits management company, today announced it has achieved over 100% revenue growth in 2017. Progyny’s innovative carve-out fertility benefits [...]
athenahealth Announces Fourth Quarter and Full Year 2017 Earnings Conference Call
08/01/2018
WATERTOWN, Mass., Jan. 08, 2018 (GLOBE NEWSWIRE) -- athenahealth, Inc. (NASDAQ: ATHN ), a leading provider of network-enabled services for hospital and ambulatory clients nationwide, today announced that it will hold a [...]
Editas Medicine Reports on Recent Progress and Announces “EM22” Five-year Goals at J.P. Morgan Healthcare Conference
08/01/2018
By the end of 2022, Company expects to have three experimental medicines in early-stage clinical trials and two experimental medicines in or ready for late-stage clinical trials Announces first acquisition with purchase [...]
Rexahn Pharmaceuticals to Present at Biotech Showcase™ 2018
08/01/2018
ROCKVILLE, Md., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a clinical stage biopharmaceutical company developing next generation therapeutics for the treatment of cancer, [...]
Resverlogix and Medison Pharma Ltd. Announce Strategic Licensing Agreement
08/01/2018
CALGARY, Alberta, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX: RVX ) today announced that it has entered into a licensing agreement with Medison Pharma Ltd. (“Medison”) for [...]
RespireRx Pharmaceuticals Inc. to Present at 10th Annual Biotech Showcase™ 2018
08/01/2018
CEO to Review completed Phase IIB dronabinol trial for the treatment of Obstructive Sleep Apnea (OSA) and Provide Pipeline update Glen Rock, N.J., Jan. 08, 2018 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC QB [...]
Olainfarm will Hold Third Quarter 2017 and Latest Corporate News Investor Conference Webinar
08/01/2018
Olaine, 2018-01-08 14:42 CET (GLOBE NEWSWIRE) -- Webinar will be hosted by the Member of the Management Board Salvis Lapiņš. The presentation will be held in English. During the webinar Salvis Lapiņš will inform about [...]
Anthera Pharmaceuticals Announces Results of Special Meeting of Stockholders
08/01/2018
HAYWARD, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ) is pleased to announce the results of the Special Meeting of Stockholders held on January 5, 2018. Shareholders approved [...]
Xenon Pharmaceuticals Outlines Key Milestones for 2018
08/01/2018
BURNABY, British Columbia, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE ), a clinical-stage biopharmaceutical company, today provided a corporate update and outlined its anticipated key [...]
pSivida Submits New Drug Application (NDA) for Durasert™ Three-Year Treatment for Posterior Segment Uveitis to the U.S. FDA
08/01/2018
WATERTOWN, Mass., Jan. 08, 2018 (GLOBE NEWSWIRE) -- pSivida Corp. (NASDAQ: PSDV ) (ASX:PVA), a leader in the development of sustained release drug products and technologies, today announced it has submitted its New Drug [...]
ChemoCentryx Strengthens Senior Executive Team with the Appointment of William Fairey as Executive Vice President and Chief Operating Officer
08/01/2018
MOUNTAIN VIEW, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI ), a biopharmaceutical company developing new medications targeted at inflammatory and autoimmune diseases and cancer, today [...]

Pages